See also this year's filing and all EDGAR filings for this company.
PDF Report 0001755237_2023_Cyclerion_Therapeutics_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2': 2, '100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 11}} |
Graph
Absolute values for 0001755237, Cyclerion Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,820,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,259,000 |
| 4 | LiabilitiesCurrent | 7,627,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,504,000 |
| 9 | ResearchAndDevelopmentExpense | 31,493,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,625,000 |
| 12 | remainder_NetIncome | 294,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,079,000 |
| 1 | Liabilities | 7,627,000 |
| 2 | Expenses | 45,997,000 |
| 3 | Revenues | 1,625,000 |
| 4 | StockholdersEquity | 10,452,000 |
| 5 | NetIncome | -44,078,000 |
| 6 | ComprehensiveNetIncome | -44,078,000 |
| 7 | BaseVar | 36,811,000 |
| 8 | EconomicCapitalRatio | -2.03 |
Edgar->Model Mapping
Feature Distribution
Change over Time
